Skip to main content
PharmacoEconomics Open logoLink to PharmacoEconomics Open
. 2022 Jul 1;6(4):629. doi: 10.1007/s41669-022-00345-3

Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries

Anna-Maria Fontrier 1,, Erica Visintin 1, Panos Kanavos 1
PMCID: PMC9283592  PMID: 35776409

Correction to: PharmacoEconomics – Open (2022) 6:315–328 10.1007/s41669-021-00311-5

This article incorrectly reported that the two German health technology assessment (HTA) bodies, G-BA and IQWiG, only assess pharmaceuticals. The article should have indicated that these bodies also evaluate medical devices and other health technologies. The article and supplement have been corrected.

In addition, the name of the Austrian HTA body has been updated from “Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA)” to “Austrian Institute for Health Technology Assessment (AIHTA)”, as AIHTA was established in March 2020 to succeed LBI-HTA. Finally, the term “HTA authority” has been changed to “HTA body” throughout the manuscript to avoid any confusion to the reader, as the term “authority” might be misinterpreted as meaning that the HTA recommendations are legally binding.


Articles from PharmacoEconomics Open are provided here courtesy of Springer

RESOURCES